Research articlePublished 21 Nov 2016
Development and Validation of Five Simple UV-Spectrophotometry Methods for Estimation of Anagliptin in Bulk and in-house Tablets
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Anagliptin is a Dipeptidyl peptidase-4 (DPP-4) inhibitor used in the treatment of diabetes. Five simple, specific, sensitive, rapid and economical UV- Spectrophotometry methods have been established for the determination of Anagliptin in bulk and in-house tablets. All five methods of UVSpectrophotometry based upon Zero Order, First Order and Second Order derivative Spectrophotometry have been established considering amplitude and Area under Curve of the spectrum. In all five methods, Anagliptin obeyed linearity in the concentration range of 2-8 μg/mL with correlation coefficient (r2>0.999). The % amount of drug estimated in the developed methods was found to be good agreement with label claimed in in-house tablet formulation. All the methods were validated as per International conference on Harmonization (ICH) guidelines. All these proposed methods were proved to be linear, accurate, precise and rugged and also adequately sensitive.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Methods
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Amod S Patil”
- BylineArticles whose byline prints “Atul A Shirkhedkar”